58 related articles for article (PubMed ID: 6133426)
1. Nature of polypeptides synthesized in influenza a virus-infected nonpermissive cells of the immune system.
Leontyeva GF; Dubrovina TY; Taros LY; Polyak RY
Acta Virol; 1983 Jan; 27(1):12-20. PubMed ID: 6133426
[TBL] [Abstract][Full Text] [Related]
2. Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes.
Gujuluva CN; Kundu A; Murti KG; Nayak DP
Virology; 1994 Nov; 204(2):491-505. PubMed ID: 7941316
[TBL] [Abstract][Full Text] [Related]
3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of the abortive reproduction of influenza A virus in human embryo amniotic cells: the synthesis of virus-specific RNA and proteins].
Guskin IaR
Mikrobiol Zh (1978); 1980; 42(5):653-5. PubMed ID: 7432212
[No Abstract] [Full Text] [Related]
5. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.
Chan W; Zhou H; Kemble G; Jin H
Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193
[TBL] [Abstract][Full Text] [Related]
6. The effect of cell density on influenza virus replication in CV-1 cells.
Kaverin NV; Klenk HD
Mol Gen Mikrobiol Virusol; 1995; (2):26-33. PubMed ID: 7477030
[TBL] [Abstract][Full Text] [Related]
7. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus.
Ueda M; Yamate M; Du A; Daidoji T; Okuno Y; Ikuta K; Nakaya T
Virus Res; 2008 Sep; 136(1-2):91-7. PubMed ID: 18550190
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the mechanisms of resistance to influenza virus of cells of the immune system].
Poliak RIa; Dubrovina TIa; Leont'eva GF; Smorodintsev AA
Dokl Akad Nauk SSSR; 1980; 251(3):725-8. PubMed ID: 7379693
[No Abstract] [Full Text] [Related]
9. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
[TBL] [Abstract][Full Text] [Related]
10. Efficient translation of mRNAs in influenza A virus-infected cells is independent of the viral 5' untranslated region.
Cassetti MC; Noah DL; Montelione GT; Krug RM
Virology; 2001 Oct; 289(2):180-5. PubMed ID: 11689040
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
12. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
13. A novel synthetic reversible inhibitor of sialidase efficiently blocks secondary but not primary influenza virus infection of MDCK cells in culture.
Barrère B; Driguez PA; Maudrin J; Doutheau A; Aymard M; Quash G
Arch Virol; 1997; 142(7):1365-80. PubMed ID: 9267449
[TBL] [Abstract][Full Text] [Related]
14. Kinetic profile of influenza virus infection in three rat strains.
Daniels MJ; Selgrade MK; Doerfler D; Gilmour MI
Comp Med; 2003 Jun; 53(3):293-8. PubMed ID: 12868575
[TBL] [Abstract][Full Text] [Related]
15. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
Zhou K; He H; Wu Y; Duan M
J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
[TBL] [Abstract][Full Text] [Related]
16. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
Min JY; Li S; Sen GC; Krug RM
Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
[TBL] [Abstract][Full Text] [Related]
17. Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells.
Melik-Nubarov NS; Suzdaltseva YuG ; Priss EL; Slepnev VI; Kabanov AV; Zhirnov OP; Sveshnikov PG; Severin ES
Biochem Mol Biol Int; 1993 Apr; 29(5):939-47. PubMed ID: 8508145
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live-attenuated vaccine candidate in the mouse model.
Liu B; Hossain MJ; Mori I; Kimura Y
J Med Virol; 2008 May; 80(5):888-94. PubMed ID: 18360902
[TBL] [Abstract][Full Text] [Related]
19. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.
Matikainen S; Pirhonen J; Miettinen M; Lehtonen A; Govenius-Vintola C; Sareneva T; Julkunen I
Virology; 2000 Oct; 276(1):138-47. PubMed ID: 11022002
[TBL] [Abstract][Full Text] [Related]
20. Influenza A virus-induced apoptosis is a multifactorial process: exploiting reverse genetics to elucidate the role of influenza A virus proteins in virus-induced apoptosis.
Morris SJ; Nightingale K; Smith H; Sweet C
Virology; 2005 May; 335(2):198-211. PubMed ID: 15840519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
